papaverine has been researched along with midodrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benbouzid, R; Enjalbert, M; Hadiji, N; Leblond, C; Mieusset, R; Previnaire, JG; Soler, JM | 1 |
1 review(s) available for papaverine and midodrine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for papaverine and midodrine
| Article | Year |
|---|---|
[Evaluation of the management of erectile and ejaculatory dysfunction in a series of 90 patients with spinal cord injuries].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Alprostadil; Ejaculation; Erectile Dysfunction; Humans; Male; Massage; Middle Aged; Midodrine; Papaverine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Retrospective Studies; Sexual Dysfunction, Physiological; Spinal Cord Injuries; Vasodilator Agents; Vibration; Young Adult | 2013 |